Ozempic® (semaglutide), weekly pen

How common are Ozempic side effects, and what is “Ozempic face”?

Ozempic is semaglutide in a weekly pen, which the FDA approved for type 2 diabetes. Taking it purely to lose weight is off-label. An AM Rx provider goes through your health history online and says which GLP-1 medicine fits you, if any.

  • A diabetes medicine by FDA approval; weight loss use is off-label
  • Brand Ozempic copay as low as $25/mo if your insurance covers it*
  • New intakes are read by a licensed provider in 1 to 2 business days
  • Open to eligible adults in every state and Washington, DC
Two Ozempic injection pens
Ozempic brand pens · $25/mo possible with coverage*
Illustration of a medication vial in front of a cardboard shipping box
Compounded semaglutide · from $106/mo† · not FDA-approved
Phone screen asking “What is your desired weight?” beside a medication card
Your intake goes to a licensed provider
$25/moLowest brand Ozempic copay with coverage*
$106/moCompounded semaglutide, 3-month order†
$39First month of AM Rx membership
What is Ozempic approved to treat?

Novo Nordisk’s Ozempic won FDA approval on December 5, 2017.1 Its label carries three uses, each for adults who have type 2 diabetes: blood sugar control, lower heart risk when heart disease is present, and lower kidney risk when chronic kidney disease is present.2 A weight-only prescription is therefore off-label.

How is Ozempic different from Wegovy®?

Same ingredient (semaglutide), same company, different approvals. The Ozempic label covers type 2 diabetes and tops out at 2 mg weekly. Wegovy carries the weight management approval, usually at 2.4 mg weekly.3 Without diabetes, Wegovy is the on-label product for weight loss.

*Depends on commercial insurance that includes Ozempic. The Novo Nordisk savings offer stops at $100 off per month, is limited to FDA-approved uses, and is closed to people on Medicare, Medicaid, TRICARE, the VA or another government plan. †With a 3-month order; $199 if billed monthly. Compounded medication is not FDA-approved. Membership ($39, then $135 a month) is extra.

Safety summary: Ozempic has a boxed warning for possible thyroid tumors. Nobody with medullary thyroid carcinoma (MTC) in their own or their family’s history, and nobody with MEN 2 (multiple endocrine neoplasia type 2), should take it. Full safety information.

On 1 mg of semaglutide, an Ozempic dose, trial volunteers lost 7.2% of their weight

The number comes from STEP 2, a trial of 1,210 adults with a BMI of at least 27 who also had type 2 diabetes, all given lifestyle counseling.4 After 68 weeks the 1 mg group, one of Ozempic’s doses, was 7.2% lighter on average. The placebo group was 3.3% lighter, and the 2.4 mg group, the strength sold as Wegovy, 9.9%.5

7.2% of that, the
1 mg group’s average
18lbs

Placebo group’s average: 8 lbs. Wegovy-dose group: 25 lbs

This multiplies your weight by one trial group’s average and predicts nothing about you: individuals lost far more or far less. Averages are as posted on ClinicalTrials.gov; the journal paper adjusts for missing data and reports 9.6% (2.4 mg) and 3.4% (placebo).

What Ozempic’s label trials recorded

Those trials targeted blood sugar and logged weight on the side, in kilograms. Volunteers in the two below started at 89 to 100 kg (196 to 221 lb) on average.2

TrialWeight lost, on averageComparison group
SUSTAIN 1 (30 weeks, 388 adults)3.8 kg (8.4 lb) on 0.5 mg
4.7 kg (10.4 lb) on 1 mg
1.2 kg (2.6 lb) on placebo
SUSTAIN FORTE (40 weeks, 961 adults)5.6 kg (12.3 lb) on 1 mg
6.4 kg (14.1 lb) on 2 mg
No placebo group. Per the label, the two doses did not differ significantly.

At Ozempic’s strengths, then, the average loss in a 30- to 40-week diabetes trial was between 8 and 14 pounds. Announcing the 2 mg dose in 2022, Novo Nordisk wrote that Ozempic “is not a weight loss drug, but may help people lose some weight.”6 See also Wegovy and semaglutide.

What Ozempic is, and what the FDA approved it for

Ozempic is a brand of semaglutide, a GLP-1 receptor agonist injected once a week. Its label lists three uses, every one for an adult who has type 2 diabetes. Weight loss is not on the list.2

FeatureOzempicDiabetes approvalWegovyWeight approvalCompounded semaglutideNo FDA approval
FDA statusApprovedApprovedNot FDA-approved: compounded drugs get no FDA review of safety, effectiveness or quality7
Label coversType 2 diabetes, plus lower heart and kidney risk in people who have itWeight management, lower heart risk, and the liver disease MASH3No label
Used for weight lossOff-labelOn-labelNo approved use

How Ozempic works

Your gut makes a hormone called GLP-1 after you eat. Semaglutide is built to imitate it, sharing 94% of the natural hormone’s sequence and binding to the same receptor.2

For type 2 diabetes, three effects matter. High blood sugar triggers extra insulin from the pancreas. Levels of glucagon, a hormone that raises blood sugar, fall. Food also leaves the stomach more slowly.2 People also eat less: the Wegovy label reports lower calorie intake on semaglutide, likely through appetite.3

One dose a week is enough because the half-life is roughly seven days. After a final dose, semaglutide lingers in the bloodstream for about 5 weeks.2

Ozempic at a glance

  • Pen strengths: 0.25 or 0.5 mg, 1 mg, and 2 mg. A tablet form of Ozempic is sold as well8
  • Safety and effectiveness in children have not been established
  • Carries a thyroid C-cell tumor boxed warning (see the safety information)

Getting Ozempic through AM Rx, step by step

Everything runs through your AM Rx account, with nothing to book in advance: a licensed provider reads what you submit and answers by secure message.

Five steps, intake to first dose
1. Tell us about your health

Membership is $39 for month one. The questionnaire asks for diagnoses, current medicines and thyroid history. Mention type 2 diabetes if you have it, and any insulin or sulfonylurea, since each changes what can be prescribed.

Phone screen asking “What is your desired weight?” beside a medication card
2. A provider reads your answers

A U.S.-licensed, board-certified physician or nurse practitioner reviews new intakes within 1 to 2 business days. No diabetes? You will hear it straight: Ozempic purely for weight is off-label, and another medicine may be the better match.

Hands holding a phone that shows a message thread with a provider
3. Our team handles insurance forms

For a brand-name drug, AM Rx’s insurance coordination team sends in the prior authorization. A decision usually takes 2 to 14 business days, and the team can submit as many as three requests if the first is denied. Approval cannot be promised, and the authorization lasts only while your membership is active.

A woman laughing while looking at her phone
4. The pharmacy fills it

A brand-name Ozempic prescription goes to whichever pharmacy you pick. If your provider decides compounded semaglutide is appropriate instead, a partner pharmacy mails it, typically 2 to 9 business days later. Compounded medication is not FDA-approved.

Illustration of a medication vial in front of a cardboard shipping box
5. Check in when the dose goes up

Side effects tend to appear when the dose rises, so write to your provider or care team whenever you need to. Coaching and optional monthly visits are included.

A woman in workout clothes laughing against a red wall

What your AM Rx membership pays for

  • Your intake read by a licensed provider, who prescribes only when appropriate
  • Prior authorization paperwork for brand-name drugs
  • Unlimited secure messages to your provider and care team
  • A monthly video or phone visit if you want one
  • Your own weight loss coach
  • AM Rx’s app and web portal

The price

$39for month one, $135 a month after.

Medication costs extra. Cancel in the portal whenever you like. HSA and FSA cards are accepted.

Get Started

Ozempic side effects, with how often each was reported

Nausea leads the list. In the placebo-controlled trials behind the label, about one in six people on 0.5 mg (15.8%) and one in five on 1 mg (20.3%) reported it, against 6.1% on placebo.2

Side effect0.5 mg1 mgPlacebo
Nausea15.8%20.3%6.1%
Vomiting5%9.2%2.3%
Diarrhea8.5%8.8%1.9%
Stomach pain7.3%5.7%4.6%
Constipation5%3.1%1.5%
At least one stomach or gut effect32.7%36.4%15.3%
Quit treatment over one3.1%3.8%0.4%

Two placebo-controlled trials in type 2 diabetes; 521 people used Ozempic, for 32.9 weeks on average.2

Easing the usual ones

  • Eat smaller meals more often: a small breakfast, then something small every 3 to 4 hours, per a 2025 nutrition advisory.9
  • For nausea in the first days of treatment, skip fatty and high-fiber food.9
  • Constipated? Add fiber back slowly through food, and drink more.9
  • With vomiting or diarrhea, keep sipping fluids to protect your kidneys.2

Get medical help right away if

  • Your face, lips, tongue or throat swell, or breathing becomes hard. Stop Ozempic.
  • Stomach pain is bad and does not let up. Stop Ozempic.
  • Sight in one eye suddenly goes

When do Ozempic side effects start, and when do they ease?

They gather around dose changes. The label places the bulk of nausea, vomiting and diarrhea reports in the weeks when doses were stepped up, hence the low 0.25 mg start.2 It offers no timetable in days.

Follow people for longer and more of them report something: across STEP 2’s 68 weeks, 57.5% of the 1 mg group had a stomach or gut complaint, versus 34.3% on placebo, mostly mild to moderate.4

Side effects that are less common

More than 0.4% of people noticed tiredness, dizziness or a change in taste, and 0.2% had redness or soreness where they injected. Tests showed a resting pulse 2 to 3 beats a minute faster, and average rises of 13% in amylase and 22% in lipase, two pancreatic enzymes.2

Hair loss, headache and odd skin sensations are named as well, but only from reports after approval, so no percentage exists.2

Low blood sugar

As the only diabetes drug in a 30-week trial, Ozempic caused no severe low blood sugar. With a sulfonylurea, severe episodes affected 0.8% to 1.2% of people and milder documented ones 17.3% to 24.4%.2 Insulin raises the risk too, so a provider may cut the dose of either drug when Ozempic begins.

The label’s serious warnings, and what should prompt a call

WarningWhat has been reportedContact your provider about
Thyroid C-cell tumors (the boxed warning)Rats and mice given semaglutide developed them. Nobody knows if people do.2A neck lump or swelling, a hoarse voice, hard swallowing or shortness of breath.
PancreatitisAcross the blood sugar trials, 7 cases were confirmed on Ozempic (0.3 per 100 patient-years) and 3 on comparison drugs (0.2).2Bad stomach pain that does not let up and may spread to your back. Stop Ozempic and call at once.
Diabetic eye diseaseOver 2 years, retinopathy complications affected 3.0% on Ozempic and 1.8% on placebo; with retinopathy beforehand, 8.2% and 5.2%.2Any change in your sight.
Optic nerve damage (NAION)On November 9, 2026 the FDA ordered a warning onto all GLP-1 labels after counting 6.4 NAION cases for every 100,000 person-years on these drugs versus 3.8 on comparators. Ozempic’s label is not yet updated.10Sudden loss of vision in one eye, usually painless. Reach a health professional right away.
Kidney injuryPost-approval reports, some ending in dialysis, mostly in people dehydrated by vomiting or diarrhea.2Vomiting, diarrhea or nausea that drags on.
Severe stomach problemsSevere gut reactions hit 0.4% (0.5 mg) and 0.8% (1 mg) of people and no one on placebo. Not advised with severe gastroparesis.2Digestive symptoms that are severe or will not ease.
Gallbladder problemsGallstones formed in 1.5% (0.5 mg) and 0.4% (1 mg) of people and no one on placebo.2Clay-colored stools, yellowing skin or eyes, fever, or pain high in the stomach.
Serious allergic reactionAnaphylaxis and angioedema are on record.2A swollen face, lips, tongue or throat, difficult breathing, a severe rash or fainting. Stop Ozempic and get medical help immediately.
AnesthesiaRarely, stomach contents have reached the lungs under general anesthesia or deep sedation.2Any planned operation or procedure. Every provider involved should know you use Ozempic.

Ozempic is ruled out for anyone who has had medullary thyroid carcinoma or has it in the family, anyone with MEN 2, and anyone who once reacted seriously to semaglutide.2 The safety information has the full list, and our GLP-1 side effects guide covers the whole drug class.

How Ozempic doses step up

The first four weekly injections are 0.25 mg, and from week five the dose is 0.5 mg. Later a provider can raise it to 1 mg, and after that to 2 mg, the label’s limit.2

StageDose each weekPurpose
First 4 weeks0.25 mgStarter amount, kept low to limit stomach side effects
From the fifth week0.5 mgThe lowest maintenance dose
4 weeks or longer at 0.5 mg1 mgMore blood sugar control; the label’s maintenance dose in chronic kidney disease
4 weeks or longer at 1 mg2 mgThe ceiling
  1. 0.25 mgFirst 4 weeks
  2. 0.5 mgWeek 5 onward
  3. 1 mgOptional
  4. 2 mgTop dose

Body weight does not change the dose. Inject just under the skin of your stomach area, thigh or upper arm, on a fixed day each week. A forgotten dose can be taken up to 5 days late.2 See our Ozempic dosage guide for pens, missed doses and storage.

“Ozempic face”: what the term means and what studies show

“Ozempic face” is slang for a face that looks hollow or older after weight comes off quickly. The phrase, and anything like it, is absent from the side effects in Ozempic’s prescribing information.2

Facial plastic surgeons describe a face that has lost fat and volume, leaving wrinkles and sagging skin.11

Is Ozempic face from the drug or from losing weight?

Chiefly from losing weight, whatever the method. In a 2018 study, plastic surgeons guessed people’s ages from their faces before and after weight loss surgery: 40.8 years on average before, 43.7 a year after.12 A 2024 review of 14 studies of weight loss by surgery or medicine agreed that heavy weight loss ages the face, chiefly by emptying the mid-cheek and loosening neck skin.13

One small study has put numbers on it for GLP-1 medicines, comparing head scans from before and after treatment in 20 patients who lost 11 kg (about 24 lb) on average. The midface lost a median 9% of its volume, and patients who lost more weight lost more facial fat.14 Twenty patients at one hospital make an early estimate, no more.

Whether semaglutide also affects skin by another route is not settled. A 2025 review suggested mechanisms beyond fat loss and said they remain to be worked out.15

How often does it happen on Ozempic?

No one can say, because no trial has counted cases. The evidence does link it to the amount of weight lost, and average losses in Ozempic’s label trials ran from 3.2 to 6.4 kg, far below the scan study’s 11 kg.2

Is there a treatment?

The change is to appearance, so treatment is cosmetic and optional. Surgeons mention dermal fillers, skin tightening and surgery.11 We found no study on whether the face refills unaided, so we make no claim.

Lowering the odds

  • Aim for gradual loss. A 2026 review of 40 studies named rapid loss as a risk factor for skin changes.16
  • Get enough protein and fluids. The review tied low protein intake and poor hydration to worse results.16
  • Losing faster than planned? Tell your provider and ask about staying on your current dose.
Checked November 19, 2026

Ozempic cost: with insurance, without it, and through AM Rx

A pen of Ozempic lists at $1,027.51, though hardly anyone pays that.17 With commercial coverage, the Novo Nordisk savings offer can take a fill down to $25. Out of pocket, most strengths cost $349 a month from Novo Nordisk.8

If you haveLikely priceFine print
Commercial insurance, Ozempic coveredFrom $25 per fillThe savings offer from Novo Nordisk takes as much as $100 off a one-month fill and lasts up to 48 months. Only prescriptions for an FDA-approved use qualify.8
No coverage for Ozempic$349 monthly, or $499 at 2 mgThis is Novo Nordisk’s self-pay rate. Until December 31, 2026, new patients are charged $199 for each of their first two fills at 0.25 mg or 0.5 mg.8
Medicare Part DYour plan decidesNovo Nordisk says most Part D plans cover it.18 Ozempic is not in the $50-a-month Medicare GLP-1 Bridge.19
MedicaidYour state decidesEvery state has to cover GLP-1 drugs for diabetes. Obesity coverage is a state choice, and 13 programs had it in January 2026.20
A low income$0 if you qualifyThe Patient Assistance Program run by Novo Nordisk supplies Ozempic free to people within its income limits who lack government drug coverage.18

Ozempic cost with insurance

The reason for the prescription drives the insured price. Most commercial plans cover Ozempic, Novo Nordisk says, depending on their drug lists and on the FDA-approved use, type 2 diabetes.18 Weight loss is another matter: just 18% of employers with 200 or more workers cover GLP-1 drugs taken mainly for it.21

Two examples on a covered one-month fill: a $90 copay becomes $25, and a $160 copay loses the full $100 and becomes $60. Medicare, Medicaid, TRICARE, VA benefits or any other government insurance rule the offer out, as does a prescription written purely for weight loss.8

Ozempic cost without insurance

Paying out of pocket means Novo Nordisk’s self-pay rate: $349 a month up to the 1 mg dose, $499 a month at 2 mg.8 These purchases bypass insurance, so no plan will reimburse them or apply them to your deductible.

The $199 starter price covers two monthly fills, then reverts to $349. “New patient” means no Ozempic savings offer used in 365 days at a retail pharmacy, or no Ozempic ever filled through NovoCare home delivery.8,22

What AM Rx charges

  • Membership: $39 the first month and $135 each month after, separate from medication.
  • Brand-name Ozempic: your plan’s copay at your chosen pharmacy, as low as $25 a month with coverage.
  • Compounded semaglutide, only if a provider finds it appropriate: $199 billed monthly or, with a 3-month order, from $106 a month. Shipping is included. It is not FDA-approved: the FDA does not check compounded drugs for safety, effectiveness or quality.
  • Semaglutide bundle: $217 in month one and $297 a month afterward, membership and compounded medication together. Doses above the standard schedule can add fees.

Thinking of Ozempic just for weight loss? Insurance tends to pay for Ozempic only as a diabetes treatment. The medicines the FDA approved for weight are Wegovy and Zepbound®. Our GLP-1 insurance coverage tool shows what plans usually require.

Direct from the manufacturer

NovoCare delivers Ozempic, but someone else must prescribe it

Novo Nordisk runs NovoCare, a home delivery service for Ozempic and Wegovy. Shipping is free, you can pay out of pocket or through insurance, and every dose needs a prescription.23

FeatureAM RxNovoCare home delivery
Who judges whether Ozempic fitsAn AM Rx provider who has read your health historyYour own prescriber, or a telehealth prescriber NovoCare refers you to
What can be prescribed or filledFour GLP-1 brands and, when appropriate, compounded optionsOzempic and Wegovy only
Care after you startMessaging, visits and coaching come with membershipUp to your prescriber

NovoCare information checked November 2026. AM Rx has no affiliation with Novo Nordisk or NovoCare.

Ozempic next to Wegovy, Zepbound and Mounjaro

Ozempic and Mounjaro® hold diabetes approvals; Wegovy and Zepbound hold weight approvals. Each trial below enrolled a different kind of patient, so read across rows with care.

FeatureOzempicWegovyZepboundMounjaro
Active ingredientSemaglutideSemaglutideTirzepatideTirzepatide
FDA approvalType 2 diabetesWeight managementWeight management; sleep apnea with obesity24Type 2 diabetes25
Has a weight loss approvalNoYesYesNo
Dose range0.25 mg to 2 mg0.25 mg to 7.2 mg2.5 mg to 15 mg2.5 mg to 15 mg
Average weight lost in a main trial7.2% on 1 mg vs 3.3% on placebo (STEP 2; 68 weeks; type 2 diabetes)14.9% on 2.4 mg vs 2.4% on placebo (STEP 1; 68 weeks; no diabetes)315.0% to 20.9% vs 3.1% on placebo (SURMOUNT-1; 72 weeks; no diabetes)247.6 to 11.2 kg vs 5.7 kg on semaglutide 1 mg (SURPASS-2; 40 weeks; type 2 diabetes)25
Nausea in the label’s trials15.8% to 20.3% (6.1% on placebo)44% (16% on placebo)325% to 29% (8% on placebo)2412% to 18% (4% on placebo)25

Of the trials in this table, only SURPASS-2 tested two of the drugs against each other, using semaglutide 1 mg, an Ozempic strength.25 The labels caution that rates from separate trials are not directly comparable.2 More in our Mounjaro vs Ozempic guide.

Zepbound, Ozempic, Mounjaro and Wegovy pens side by side on a green background

Could another GLP-1 be the better choice?

When appropriate for you, an AM Rx provider can prescribe any of these four brands or a compounded option. The membership fee is the same for each.

AM Rx members

What AM Rx members say about their care

One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
Michelle, 33 | Lost 48 pounds
I started semaglutide at the recommendation of my AM Rx provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Michael, 37 | Lost 29 pounds
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and AM Rx was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Susanne, 60 | Lost 33 pounds
Since I started AM Rx, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
Rachel | AM Rx Member
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
John | AM Rx Member
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Sara | AM Rx Member

Individual results may vary. These reviews describe the experience of individual AM Rx members and do not promise any result. Medication is prescribed only if a licensed provider considers it appropriate.

A man at home smiling at his laptop
Your care team

A licensed provider reads your history before Ozempic is prescribed

Ozempic carries a boxed warning. An AM Rx provider checks your diagnoses, medicines and thyroid history first, and tells you plainly when another treatment suits you better.

50 states and DCU.S.-licensed physicians and nurse practitioners, wherever you live
No appointment to bookA provider reads your intake online and replies by secure message
Open every dayPhone support Monday to Friday 9am to 8pm ET, weekends 12pm to 8pm ET

The AM Rx care team checks the medical content of this page against FDA prescribing information and published clinical trials. It is general health education and does not replace advice from your own provider.

Ozempic questions, answered

Can Ozempic be prescribed for weight loss?

Yes, but only off-label. The FDA approved Ozempic for people with type 2 diabetes: for blood sugar, and for lowering heart and kidney risk.2 Weight loss is not an approved use, and insurance seldom pays for it. Wegovy is the semaglutide product with a weight management approval.

What is the most common side effect of Ozempic?

Nausea. The label’s placebo-controlled trials recorded it in 15.8% of people taking 0.5 mg and 20.3% taking 1 mg, while 6.1% of the placebo group had it. Diarrhea, vomiting, stomach pain and constipation come next, none reaching 10%.2 See the side effect table.

Do Ozempic side effects go away?

No promise of that appears in the label, which also sets no number of days. It does say reports of nausea, vomiting and diarrhea were concentrated in dose escalation, the weeks when the dose climbs.2 Message your provider about symptoms that are severe or will not settle.

What is Ozempic face, and will I get it?

A nickname for hollowed cheeks and loosened facial skin after quick weight loss. It is not a diagnosis, and Ozempic’s label does not mention it.2 No trial has measured how often it happens. One small scan study estimated a 7% loss of midface volume per 10 kg (22 lb) lost.14

Can you prevent Ozempic face?

Nothing is proven to prevent it. Researchers single out speed and nutrition: a 2026 review of 40 studies tied worse skin changes to rapid weight loss, older age, and too little protein or fluid, and recommended gradual loss.16 Tell your provider if you are losing faster than intended.

Does Ozempic cause hair loss?

It may. The Ozempic label lists hair loss among reports received after approval, which carry no percentage.2 The Wegovy label, for the stronger 2.4 mg dose, gives one: 3% of adults on the drug versus 1% on placebo, tied to weight reduction.3

Can Ozempic affect your eyesight?

Yes, in two ways. Diabetic retinopathy complications appeared in 3.0% of Ozempic users and 1.8% of placebo users in a 2-year trial.2 The other is NAION, a rare optic nerve condition that the FDA ordered onto all GLP-1 labels on November 9, 2026.10 Sudden sight loss in one eye needs immediate care.

What is the average weight loss on Ozempic?

Between 3.8 and 6.4 kg (roughly 8 to 14 lb) in two label trials lasting 30 to 40 weeks.2 STEP 2 ran 68 weeks, and its 1 mg group averaged 7.2% against 3.3% for placebo.5 Individual results differ widely, and weight loss is not an approved use.

Important safety information

Boxed warning: thyroid C-cell tumors

In rats and mice, semaglutide produced tumors in the thyroid’s C cells. No one knows if Ozempic does so in humans, or if it can cause the thyroid cancer known as medullary thyroid carcinoma (MTC). Ozempic is off limits to anyone who has had MTC or has a relative who has, and to anyone with the syndrome called multiple endocrine neoplasia type 2 (MEN 2). Report hoarseness, difficulty swallowing, breathlessness, or a neck lump or swelling to your provider.

Ozempic is not for you if

  • MTC has affected you or a family member, or you have MEN 2
  • semaglutide, or anything else in Ozempic, has given you a serious allergic reaction

Before starting, your provider needs to know if you

  • have ever had pancreas trouble
  • have had diabetic retinopathy
  • have gastroparesis (a stomach that empties slowly) or other serious digestive problems
  • use insulin or a sulfonylurea
  • have an operation or a procedure with anesthesia or deep sedation coming up
  • are pregnant, hope to become pregnant, or are breastfeeding. Ozempic should be stopped 2 months or more ahead of a planned pregnancy

This summary is not the whole label and is no substitute for talking with your provider. Novo Nordisk publishes the Prescribing Information and Medication Guide in full. Report side effects to the FDA at fda.gov/medwatch or by phone on 1-800-FDA-1088.

Sources

Reviewed by the AM Rx care team. Web sources were checked on November 19, 2026.

  1. FDA. Drugs@FDA application data for semaglutide (openFDA). https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name:%22SEMAGLUTIDE%22&limit=100
  2. Ozempic (semaglutide) injection prescribing information and Medication Guide. Novo Nordisk; revised May 2026. https://www.novo-pi.com/ozempic.pdf
  3. Wegovy (semaglutide) prescribing information. Novo Nordisk; revised June 2026. https://www.novo-pi.com/wegovy.pdf
  4. Davies M, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397:971-984. https://pubmed.ncbi.nlm.nih.gov/33667417/
  5. ClinicalTrials.gov. STEP 2 (NCT03552757), posted results. https://clinicaltrials.gov/study/NCT03552757
  6. Novo Nordisk. Novo Nordisk receives FDA approval of higher-dose Ozempic 2 mg. March 28, 2022. https://www.prnewswire.com/news-releases/novo-nordisk-receives-fda-approval-of-higher-dose-ozempic-2-mg-providing-increased-glycemic-control-for-adults-with-type-2-diabetes-301512209.html
  7. FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  8. Novo Nordisk. Diabetes Savings Offer Program terms, including the Ozempic self-pay offer. https://www.savingscardeligibility.com
  9. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. Obesity (Silver Spring). 2025;33:1475-1503. https://pubmed.ncbi.nlm.nih.gov/40445127/
  10. FDA. FDA requires safety labeling changes for GLP-1 receptor agonists due to potential increased risk of rare but serious eye condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
  11. Humphrey CD, Lawrence AC. Implications of Ozempic and other semaglutide medications for facial plastic surgeons. Facial Plast Surg. 2023;39:719-721. https://pubmed.ncbi.nlm.nih.gov/37541662/
  12. Valente DS, et al. Influence of massive weight loss on the perception of facial age. Plast Reconstr Surg. 2018;142:481e-488e. https://pubmed.ncbi.nlm.nih.gov/30252813/
  13. Jafar AB, et al. Soft tissue facial changes following massive weight loss secondary to medical and surgical bariatric interventions: a systematic review. Aesthet Surg J Open Forum. 2024;6:ojae069. https://pubmed.ncbi.nlm.nih.gov/39346804/
  14. Sharma RK, et al. Radiographic midfacial volume changes in patients on GLP-1 agonists. Otolaryngol Head Neck Surg. 2025;173:360-366. https://pubmed.ncbi.nlm.nih.gov/40407186/
  15. Paschou IA, et al. GLP-1RA and the possible skin aging. Endocrine. 2025;89:680-685. https://pubmed.ncbi.nlm.nih.gov/40498168/
  16. Barone M, et al. Effects of GLP-1 receptor agonists on skin quality: a comprehensive literature review. Aesthetic Plast Surg. 2026;50:5403-5407. https://pubmed.ncbi.nlm.nih.gov/42162206/
  17. Novo Nordisk. Ozempic list price. https://www.novopricing.com/ozempic.html
  18. Novo Nordisk. Ozempic cost and savings. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
  19. Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/coverage/weight-loss-drugs
  20. KFF. Medicaid coverage of and spending on GLP-1s. January 16, 2026. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
  21. KFF. 2026 Employer Health Benefits Survey. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
  22. Novo Nordisk. NovoCare home delivery offer terms. https://www.novocaredeliveryterms.com
  23. Novo Nordisk. NovoCare home delivery. https://www.novocare.com/pharmacy.html
  24. Zepbound (tirzepatide) prescribing information. Eli Lilly; revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
  25. Mounjaro (tirzepatide) prescribing information. Eli Lilly; revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
  26. American Society of Anesthesiologists. Most patients can continue diabetes, weight loss GLP-1 drugs before surgery. October 29, 2024. https://www.asahq.org/about-asa/newsroom/news-releases/2024/10/new-multi-society-glp-1-guidance
  27. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24:1553-1564. https://pubmed.ncbi.nlm.nih.gov/35441470/

See if Ozempic fits you, or if something else fits better

Fill in the health questionnaire and a licensed provider will read it. Membership is $39 for your first month.

Get Started